Eloxx Pharmaceuticals, Inc. (ELOX)

Eloxx Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018
Cash & Equivalents	19.21	42.27	24.67	22.49	48.61
Short-Term Investments	0	0	0	33.78	0
Cash & Cash Equivalents	19.21	42.27	24.67	56.28	48.61
Cash Growth	-54.56%	71.35%	-56.17%	15.78%	102.11%
Receivables	0	0	0	0.03	0
Inventory	0	0	0	0.71	0
Other Current Assets	0.92	1.21	1.23	0.7	1.74
Total Current Assets	20.13	43.48	25.89	57.71	50.34
Property, Plant & Equipment	0.99	1.66	0.55	1.13	0.25
Other Long-Term Assets	0	0	0.03	0.11	0.13
Total Long-Term Assets	0.99	1.66	0.58	1.24	0.38
Total Assets	21.12	45.14	26.48	58.95	50.72
Accounts Payable	3.02	1.38	0.48	1.87	0.75
Deferred Revenue	12.54	3.72	0.81	0.4	0
Current Debt	4.69	0.66	5.63	4.84	0
Other Current Liabilities	2.84	4.2	2.92	4.7	7.06
Total Current Liabilities	23.09	9.96	9.84	11.81	7.81
Long-Term Debt	8.69	12.8	6.41	10.93	0
Total Long-Term Liabilities	8.69	12.8	6.41	10.93	0
Total Liabilities	31.78	22.76	16.25	22.73	7.81
Total Debt	13.38	13.46	12.04	15.76	0
Debt Growth	-0.54%	11.80%	-23.63%	-	-
Common Stock	0.02	0.02	0.4	0.4	0.36
Retained Earnings	-274.39	-238.32	-171.6	-137.02	-86.15
Comprehensive Income	0	0	0	0.02	0
Shareholders' Equity	-10.66	22.38	10.23	36.21	42.91
Total Liabilities and Equity	21.12	45.14	26.48	58.95	50.72
Net Cash / Debt	5.82	28.81	12.63	40.51	48.61
Net Cash / Debt Growth	-79.79%	128.10%	-68.82%	-16.65%	102.11%
Net Cash Per Share	2.69	16.47	12.59	42.58	59.94
Working Capital	-2.96	33.53	16.06	45.9	42.53
Book Value Per Share	-4.92	12.80	10.20	38.06	52.92

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.